Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2011; 17(17): 2191-2198
Published online May 7, 2011. doi: 10.3748/wjg.v17.i17.2191
Published online May 7, 2011. doi: 10.3748/wjg.v17.i17.2191
Table 1 Baseline characteristics of the patients (n = 95) n (%)
| Characteristics | Hepatitis B patients (n = 35) | HBV carriers(n = 25) | Healthy controls (n = 35) |
| Mean age (yr) | 34.4 ± 13.5 | 31.2 ± 13.3 | 34.0 ± 9.1 |
| Sex (male/female) | 29/6 | 13/12 | 21/14 |
| Ethnic background | Han 35 (100) | Han 25 (100) | Han 35 (100) |
| Serum ALT level (IU/L) | 281 ± 59.1 | 25.3 ± 11.5 | 21.4 ± 10.2 |
| HBV DNA level (log copies/mL) | 7.68 ± 0.98 | 8.43 ± 0.89 | < 3 |
| Positive for HBeAg | 35 (100) | 25 (100) | 0 (0) |
| Prior medication for HBV | 0 (0) | 0 (0) | 0 (0) |
- Citation: Cao W, Qiu ZF, Li TS. Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients. World J Gastroenterol 2011; 17(17): 2191-2198
- URL: https://www.wjgnet.com/1007-9327/full/v17/i17/2191.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i17.2191